Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review A. Cortegiani, M. Ippolito, M. Greco, V. Granone, A. Protti, C. Gregoretti, A. Giarratano, S. Einav, M. Cecconi

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype? C.S. Kow, S.S. Hasan

Tobacco and COVID-19: A position from Sociedade Portuguesa de Pneumologia. Authors’ reply C.P. Matos, J.P. Boléo-Tomé, P. Rosa, A. Morais